Featured News
More News
Dr. David Maahs will co-direct the NIH national diabetes training program, Diabdocs, to help endocrinologists build their expertise in type 1 diabetes research and treatment
Stanford Medicine recently became the national center for a program to improve the diversity and increase the number of physician-scientists who are experts in Type 1 diabetes.
Dr. Karl Deisseroth Receives the 2023 Japan Prize!
On January 24, 2023, Dr. Karl Deisseroth , the 2018 Kyoto Prize laureate in Advanced Technology, was selected as a recipient of the “Japan Prize” in Life Sciences. Many congratulations on this prestigious recognition!
Stanford Medicine researchers including Dr. Michael Snyder measure thousands of molecules from a single drop of blood
Using a new technique called multi-omic microsampling, Stanford Medicine researchers can measure thousands of protein, fat and metabolic molecules from a single drop of blood.
Stanford Medicine scientists pinpoint COVID-19 virus’s entry and exit ports inside our noses
A discovery by Stanford Medicine researchers and colleagues may pave the way for a “morning after” or prophylactic nasal spray to prevent infection.
‘Gentle’ islet cell transplant cures mice of diabetes with few side effects, Stanford Medicine researchers (Dr. Seung Kim) say
A technique developed at Stanford Medicine allows mice with diabetes to accept unmatched islet cells and durably restores blood sugar control without immunosuppression or graft-versus-host disease.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.